Maharashtra Ayurved Center Profile
Key Indicators
- Authorised Capital ₹ 2.55 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.97 Cr
as on 16-11-2024
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.78 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit 97.20%
(FY 2023)
- Ebitda 98.56%
(FY 2023)
- Net Worth -0.87%
(FY 2023)
- Total Assets %
(FY 2023)
About Maharashtra Ayurved Center
- CIN/LLPIN
U85191PN2008PTC132396
- Company No.
132396
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2008
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Maharashtra Ayurved Center?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devendra Chitale  | Director | 28-Nov-2020 | Current |
| Avinash Belgamwar | Director | 28-Nov-2020 | Current |
| Sunita Belgamwar | Director | 09-Jul-2008 | Current |
| Sunita Masurkar | Director | 23-Mar-2009 | Current |
| Manoj Nesari | Director | 29-Jun-2009 | Current |
Financial Performance and Corporate Structure Insights of Maharashtra Ayurved Center.
Maharashtra Ayurved Center Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 97.2% increase in profit. The company's net worth dipped by a decrease of 0.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maharashtra Ayurved Center?
In 2023, Maharashtra Ayurved Center had a promoter holding of 34.02% and a public holding of 65.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indian Medicines Pharmaceutical Corporation LimitedActive 46 years 5 monthsManoj Nesari is a mutual person
- Nexus Applied Engineering Systems Private LimitedActive 30 years 8 months
Avinash Belgamwar is a mutual person
- Indian Association Of Ayurvedic PediatricsActive 16 years 5 days
Sunita Belgamwar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 10 May 2014 | ₹5.00 Cr | Open |
Idbi Bank Limited Creation Date: 10 Feb 2010 | ₹3.78 Cr | Satisfied |
Idbi Bank Limited Creation Date: 10 Feb 2010 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Maharashtra Ayurved Center?
Unlock and access historical data on people associated with Maharashtra Ayurved Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maharashtra Ayurved Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maharashtra Ayurved Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
